Biological variability of the sweat chloride in diagnostic sweat tests: A retrospective analysis

Journal of Cystic Fibrosis

Volumn 16, Issue 1, 2017, Pages 30-35

  Vermeulen, F ^a   Lebecque, P ^b   De Boeck, K ^a   Leal, T ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Hôpital Saint Luc   (Belgium)

Author keywords

Cystic fibrosis; Diagnosis; Variability

Indexed keywords

CHLORIDE;

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; CYSTIC FIBROSIS; DIAGNOSTIC TEST; HUMAN; INFANT; MEASUREMENT REPEATABILITY; NEWBORN; RETROSPECTIVE STUDY; SWEAT TEST; AGE DISTRIBUTION; BELGIUM; BIOLOGICAL VARIATION; CHEMISTRY; FEMALE; MALE; PROCEDURES; REFERENCE VALUE; STANDARDS; SWEAT; YOUNG ADULT;

AGE DISTRIBUTION; BELGIUM; BIOLOGICAL VARIATION, POPULATION; CHILD; CHLORIDES; CYSTIC FIBROSIS; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; INFANT; MALE; REFERENCE VALUES; RETROSPECTIVE STUDIES; SWEAT; YOUNG ADULT;

EID: 85009843369     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2016.11.008     Document Type: Article

References (20)

1. [1] Farrell, P.M., Rosenstein, B.J., White, T.B., Accurso, F.J., Castellani, C., Cutting, G.R., et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: cystic fibrosis foundation consensus report. J Pediatr 153 (2008), S4–S14.
2. [2] De Boeck, K., Wilschanski, M., Castellani, C., Taylor, C., Cuppens, H., Dodge, J., et al. Cystic fibrosis: terminology and diagnostic algorithms. Thorax 61 (2006), 627–635.
3. [3] Lebecque, P., Leal, T., De Boeck, C., Jaspers, M., Cuppens, H., Cassiman, J.J., Mutations of the cystic fibrosis gene and intermediate sweat chloride levels in children. Am J Respir Crit Care Med 165 (2002), 757–761.
4. [4] Thomas, M., Lemonnier, L., Gulmans, V., Naehrlich, L., Vermeulen, F., Cuppens, H., et al. Is there evidence for correct diagnosis in cystic fibrosis registries?. J Cyst Fibros 13 (2014), 275–280.
5. [5] Castellani, C., Southern, K.W., Brownlee, K., Dankert Roelse, J., Duff, A., Farrell, M., et al. European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros 8 (2009), 153–173.
6. [6] Cystic Fibrosis, F., Borowitz, D., Parad, R.B., Sharp, J.K., Sabadosa, K.A., Robinson, K.A., et al. Cystic fibrosis foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. J Pediatr 155 (2009), S106–S116.
7. [7] Massie, J., Clements, B., Australian paediatric respiratory G. diagnosis of cystic fibrosis after newborn screening: the Australasian experience—twenty years and five million babies later: a consensus statement from the Australasian paediatric respiratory group. Pediatr Pulmonol 39 (2005), 440–446.
8. [8] Koerbin, G., Greaves, R.F., Robins, H., Farquhar, J., Hickman, P.E., Total intra-individual variation in sweat sodium and chloride concentrations for the diagnosis of cystic fibrosis. Clin Chim Acta 393 (2008), 128–129.
9. [9] Vermeulen, F., Le Camus, C., Davies, J.C., Bilton, D., Milenkovic, D., De Boeck, K., Variability of sweat chloride concentration in subjects with cystic fibrosis and G551D mutations. J Cyst Fibros 16:1 (2016), 36–40.
10. [10] De Boeck, K., Kent, L., Davies, J., Derichs, N., Amaral, M., Rowe, S.M., et al. CFTR biomarkers: time for promotion to surrogate end-point. Eur Respir J 41 (2013), 203–216.
11. [11] Wanyama, S., Thomas, M., Malfroot, A., Yearly report of the Belgian cystic fibrosis registry. 2013, Institute of Public Health, Brussels, Belgium.
12. [12] LeGrys, V.A., Yankaskas, J.R., Quittell, L.M., Marshall, B.C., Mogayzel, P.J. Jr., Cystic, F.F., Diagnostic sweat testing: the cystic fibrosis foundation guidelines. J Pediatr 151 (2007), 85–89.
13. [13] Sosnay, P.R., Siklosi, K.R., Van Goor, F., Kaniecki, K., Yu, H., Sharma, N., et al. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet 45 (2013), 1160–1167.
14. [14] Mackay, R.J., Florkowski, C.M., George, P.M., Sies, C.W., Woods, S., Uncertainty of sweat chloride testing: does the right hand know what the left hand is doing?. Ann Clin Biochem 45 (2008), 535–538.
15. [15] DeMarco, M.L., Dietzen, D.J., Brown, S.M., Sweating the small stuff: adequacy and accuracy in sweat chloride determination. Clin Biochem 48 (2015), 443–447.
16. [16] Ren, C.L., Fink, A.K., Petren, K., Borowitz, D.S., McColley, S.A., Sanders, D.B., et al. Outcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening. Pediatrics 135 (2015), e1386–e1392.
17. [17] Groves, T., Robinson, P., Wiley, V., Fitzgerald, D.A., Long-term outcomes of children with intermediate sweat chloride values in infancy. J Pediatr 166 (2015), 1469–1474, e1–3.
18. [18] Williams, S.N., Nussbaum, E., Chin, T.W., Do, P.C., Singh, K.E., Randhawa, I., Diagnosis of cystic fibrosis in the kindred of an infant with CFTR-related metabolic syndrome: importance of follow-up that includes monitoring sweat chloride concentrations over time. Pediatr Pulmonol 49 (2014), E103–E108.
19. [19] Traeger, N., Shi, Q., Dozor, A.J., Relationship between sweat chloride, sodium, and age in clinically obtained samples. J Cyst Fibros 13 (2014), 10–14.
20. [20] Rock, M.J., Makholm, L., Eickhoff, J., A new method of sweat testing: the CF quantum(R)sweat test. J Cyst Fibros 13 (2014), 520–527.